作者
Mathilde Lefebvre,Ange‐Line Bruel,Émilie Tisserant,Nicolas Bourgon,Yannis Duffourd,Sophie Collardeau‐Frachon,Tania Attié‐Bitach,Paul Kuentz,Mirna Assoum,Élise Schaefer,Salima El Chehadeh,Maria Cristina Antal,Valérie Kremer,Françoise Girard-Lemaitre,Jean‐Louis Mandel,Daphné Lehalle,Sophie Nambot,Nolwenn Jean‐Marçais,Nada Houcinat,Sébastien Moutton,Nathalie Marle,Laetita Lambert,Philippe Jonveaux,B. Foliguet,Jean-Pierre Mazutti,Dominique Gaillard,Elisabeth Alanio,Celine Poirisier,Anne-Sophie Lèbre,Marion Aubert-Lenoir,Francine Arbez‐Gindre,Sylvie Odent,Chloé Quēlin,Philippe Loget,Mélanie Fradin,Marjolaine Willems,Nicole Bigi,Marie-José Perez,Sophie Blesson,Christine Francannet,A. M. Beaufrére,Sophie Patrier-Sallebert,Anne‐Marie Guerrot,Alice Goldenberg,Anne-Claire Bréhin,James Lespinasse,Renaud Touraine,Yline Capri,Marie‐Hélène Saint‐Frison,Nicole Laurent,Christophe Philippe,Frédéric Tran Mau‐Them,Julien Thévenon,Laurence Faivre,Christel Thauvin‐Robinet,Antonio Vitobello
摘要
Molecular diagnosis based on singleton exome sequencing (sES) is particularly challenging in fetuses with multiple congenital abnormalities (MCA). Indeed, some studies reveal a diagnostic yield of about 20%, far lower than in live birth individuals showing developmental abnormalities (30%), suggesting that standard analyses, based on the correlation between clinical hallmarks described in postnatal syndromic presentations and genotype, may underestimate the impact of the genetic variants identified in fetal analyses.We performed sES in 95 fetuses with MCA. Blind to phenotype, we applied a genotype-first approach consisting of combined analyses based on variants annotation and bioinformatics predictions followed by reverse phenotyping. Initially applied to OMIM-morbid genes, analyses were then extended to all genes. We complemented our approach by using reverse phenotyping, variant segregation analysis, bibliographic search and data sharing in order to establish the clinical significance of the prioritised variants.sES rapidly identified causal variant in 24/95 fetuses (25%), variants of unknown significance in OMIM genes in 8/95 fetuses (8%) and six novel candidate genes in 6/95 fetuses (6%).This method, based on a genotype-first approach followed by reverse phenotyping, shed light on unexpected fetal phenotype-genotype correlations, emphasising the relevance of prenatal studies to reveal extreme clinical presentations associated with well-known Mendelian disorders.